Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pfizer to take over NextWave Pharmaceuticals
In the second quarter of 2012, Pfizer signed an option and merger agreement with NextWave and made a $20m option payment. At present Pfizer is executing its option
In the second quarter of 2012, Pfizer signed an option and merger agreement with NextWave and made a $20m option payment. At present Pfizer is executing its option
The Ligand will earn $2m milestone payment from Merck triggered by the initiation of Phase 2b/3 trial of dinaciclib for the treatment of patients with refractory chronic lymphocytic
Amicus is developing the investigational pharmacological chaperone Migalastat HCl under collaboration with GlaxoSmithKline. Study 012, designed to compare oral migalastat HCl to ERTs (Fabrazyme and Replagal), enrolled Fabry
CTP-499 is a potential treatment developed on the basis of DCE Platform for diabetic nephropathy, a form of chronic kidney disease. The composition of matter and pharmaceutical compositions
Alnylam’s ALN-TTR program includes ALN-TTR02 and ALN-TTRsc, a subcutaneously administered RNAi therapeutic. Alnylam chief executive officer John Maraganore said ALN-TTR program holds promise as a breakthrough therapy for
The EMA’s opinion if ratified by European Commission will enable Krystexxa to treat tophaceous gout patients, who have failed to normalise serum uric acid with xanthine oxidase inhibitors
Under the new pathway, the FDA is expected to allow developers of such drugs to conduct smaller, faster clinical trials and provide a "special medical use" label enabling
Activ-Blister desiccant film technology monitors the internal atmosphere of each individual blister cavity to safe guard moisture- and oxygen-sensitive solid-dose pharmaceuticals leading to product stability, increased shelf life
The new facility will utilize 100% disposable equipment for manufacturing biologics drug substances. WuXi AppTec chairman and CEO Ge Li said the establishment of the cGMP biologics facility
The tablet, which is the AB-rated generic equivalent of Nordette, is a Levonorgestrel and Ethinyl estradiol combined oral contraceptive used to prevent pregnancy. Kurvelo tablets are being marketed